We recently compiled a list of the 13 AI News You Probably Missed. In this article, we are going to take a look at where ...

In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Amgen (AMGN – Research Report), with a price target of $383.00. The company’s shares closed yesterday at $298.84.

TD Cowen analyst Ken Cacciatore raised the firm’s price target on Biohaven (BHVN) to $75 from $55 and keeps a Buy rating on the shares. The firm said they expect Phase III data for T-alfa in SMA where ...

TD Cowen analyst Brian Morrison downgraded Linamar Corp. to hold from buy, in part because “tariff uncertainty is bound to ...

Shares of Coty (NYSE: COTY) traded lower in pre-market trading on Wednesday after TD Cowen analysts downgraded the beauty ...

We recently compiled a list of the 10 AI News and Ratings Investors Should Not Miss. In this article, we are going to take a ...

James Baugh, managing director, head of European market structure, TD Cowen was voted industry person of the year at last ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.33% of ...

Fintel reports that on November 11, 2024, TD Cowen downgraded their outlook for GCM Grosvenor (NasdaqGM:GCMG) from Buy to ...

Shares of investment management firm Onex rose Monday after TD Cowen upgraded the company's outlook on the back of its strong portfolio performance and fundraising. Shares recently traded 6.1% higher ...

Chris Krueger, MD, TD Cowen Washington Research Group, shares his thoughts on Trump’s policies when he takes office again in ...

Jeff Solomon, TD Cowen president, joins CNBC's 'Money Movers' to discuss how a Trump administration will impact the markets ...